These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2861886)

  • 1. Clinical and demographic correlates of neuroleptic response.
    Seeman MV
    Can J Psychiatry; 1985 Jun; 30(4):243-5. PubMed ID: 2861886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction.
    Kolakowska T; Williams AO; Ardern M; Reveley MA; Jambor K; Gelder MG; Mandelbrote BM
    Br J Psychiatry; 1985 Mar; 146():229-39. PubMed ID: 2859067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrophic and static (neurodevelopmental) schizophrenic psychoses: premorbid functioning, symptoms and neuroleptic response.
    Garver DL; Nair TR; Christensen JD; Holcomb J; Ramberg J; Kingsbury S
    Neuropsychopharmacology; 1999 Jul; 21(1):82-92. PubMed ID: 10379522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term neuroleptic treatment on prolactin and norepinephrine levels in serum of chronic schizophrenics: relations to psychopathology and extrapyramidal symptoms.
    Naber D; Finkbeiner C; Fischer B; Zander KJ; Ackenheil M
    Neuropsychobiology; 1980; 6(4):181-9. PubMed ID: 6104798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender and schizophrenia.
    Canuso CM; Pandina G
    Psychopharmacol Bull; 2007; 40(4):178-90. PubMed ID: 18227787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychopathologic changes in chronic schizophrenic patients following withdrawal of neuroleptics: relation to therapeutic, neuroendocrine and computer tomography variables].
    Albus M; Naber D; Ackenheil M; Bürke H; Müller-Spahn F; Münch U; Reinertshofer T; Schmidt-Vanderheyden W; Weber G; Wissmann J
    Fortschr Neurol Psychiatr; 1986 Jan; 54(1):15-20. PubMed ID: 2868983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lateral ventricular size, psychopathology, and medication response in the psychoses.
    Luchins DJ; Lewine RR; Meltzer HY
    Biol Psychiatry; 1984 Jan; 19(1):29-44. PubMed ID: 6142730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased blink rates in schizophrenics. Influences of neuroleptics and psychopathology.
    Mackert A; Flechtner KM; Woyth C; Frick K
    Schizophr Res; 1991; 4(1):41-7. PubMed ID: 1672606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computerized axial tomography scans and subtypes of schizophrenia. A review of the literature.
    Goetz KL; van Kammen DP
    J Nerv Ment Dis; 1986 Jan; 174(1):31-41. PubMed ID: 3510269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eye-blinking and cerebral ventricular size in chronic schizophrenic patients.
    Kleinman JE; Karson CN; Weinberger DR; Freed WJ; Berman KF; Wyatt RJ
    Am J Psychiatry; 1984 Nov; 141(11):1430-2. PubMed ID: 6149700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin and neuroleptic drugs.
    Green AI; Brown WA
    Endocrinol Metab Clin North Am; 1988 Mar; 17(1):213-23. PubMed ID: 2897910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
    Faraone SV; Brown WA; Laughren TP
    J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in brain structure caused by neuroleptic medication].
    Scherk H; Falkai P
    Nervenarzt; 2004 Nov; 75(11):1112-7. PubMed ID: 15365632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic withdrawal in chronic schizophrenia: CT and endocrine variables relating to psychopathology.
    Naber D; Albus M; Bürke H; Müller-Spahn F; Münch U; Reinertshofer T; Wissmann J; Ackenheil M
    Psychiatry Res; 1985 Nov; 16(3):207-19. PubMed ID: 2868473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An un-dopamine hypothesis of schizophrenia.
    Alpert M; Friedhoff AJ
    Schizophr Bull; 1980; 6(3):387-9. PubMed ID: 6105705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal and stimulated levels of prolactin, TSH, and LH in serum of chronic schizophrenic patients long-term treated with neuroleptics: relations to psychopathology.
    Naber D; Ackenheil M; Laakmann G
    Adv Biochem Psychopharmacol; 1980; 24():419-23. PubMed ID: 6105792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phases of the menstrual cycle and therapeutic response to neuroleptic therapy in patients with schizophrenia].
    Vanurová I; Yamamotová A
    Cas Lek Cesk; 2001 Oct; 140(21):668-70. PubMed ID: 11766456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
    Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal and stimulated levels of prolactin, TSH and LH in serum of chronic schizophrenic patients, long-term treated with neuroleptics.
    Naber D; Ackenheil M; Laakman G; Fischer H; von Werder K
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):325-30. PubMed ID: 6111094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.